Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-08-09 Sale |
2022-08-11 4:55 pm |
Century Therapeutics Inc. | IPSC | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage II L.P. Versant Vantage II GP L.P. Versant Vantage II GP-GP LLC 10% Owner |
550,000 | $13.03 | $7,166,610 | 12,530,909 (Indirect Direct) |
View |
| 2021-06-22 Purchase |
2021-06-23 4:41 pm |
Century Therapeutics Inc. | IPSC | BAYER AKTIENGESELLSCHAFT Bayer World Investments B.V. 10% Owner |
750,000 | $20 | $15,000,000 | 12,675,838 (Direct) |
View |
| 2021-06-22 Purchase |
2021-06-23 4:30 pm |
Century Therapeutics Inc. | IPSC | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage II L.P. Versant Vantage II GP L.P. Versant Vantage II GP-GP LLC 10% Owner |
100,000 | $20 | $2,000,000 | 13,630,909 (Indirect Direct) |
View |
| 2021-06-22 Purchase |
2021-06-22 4:31 pm |
Century Therapeutics Inc. | IPSC | Casdin Eli Director |
750,000 | $20 | $15,000,000 | 3,206,380 (Indirect) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-08-09 Other |
2022-08-11 4:55 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage II L.P. Versant Vantage II GP L.P. Versant Vantage II GP-GP LLC 10% Owner |
364,800 | $0 | 12,530,909 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:23 pm |
N/A 2032-06-09 |
Century Therapeutics Inc. | IPSC | BUTITTA CYNTHIA M Director |
19,872 | $0 | 19,872 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:23 pm |
N/A 2032-06-09 |
Century Therapeutics Inc. | IPSC | Riva Alessandro Director |
19,872 | $0 | 19,872 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:23 pm |
N/A 2032-06-09 |
Century Therapeutics Inc. | IPSC | Blackwell Kimberly Director |
19,872 | $0 | 19,872 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:22 pm |
N/A 2032-06-09 |
Century Therapeutics Inc. | IPSC | Casdin Eli Director |
19,872 | $0 | 19,872 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:22 pm |
N/A 2032-06-09 |
Century Therapeutics Inc. | IPSC | JIMENEZ JOSEPH Director |
19,872 | $0 | 19,872 (Direct) |
View |
| 2022-06-09 Option Award |
2022-06-10 4:21 pm |
N/A 2032-06-09 |
Century Therapeutics Inc. | IPSC | Carlo Rizzuto Director |
19,872 | $0 | 19,872 (Direct) |
View |
| 2022-01-31 Other |
2022-02-02 4:31 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage II L.P. Versant Vantage II GP L.P. Versant Vantage II GP-GP LLC 10% Owner |
178,996 | $0 | 13,259,905 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 4:51 pm |
N/A 2032-01-25 |
Century Therapeutics Inc. | IPSC | Diem Michael Craig Chief Business Officer |
105,000 | $0 | 105,000 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 4:51 pm |
N/A 2032-01-25 |
Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer |
105,000 | $0 | 105,000 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 4:50 pm |
N/A 2032-01-25 |
Century Therapeutics Inc. | IPSC | Borges Luis Chief Scientific Officer |
105,000 | $0 | 105,000 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 4:50 pm |
N/A 2032-01-25 |
Century Therapeutics Inc. | IPSC | Levitsky Hyam President of R&D |
105,000 | $0 | 105,000 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 4:50 pm |
N/A 2032-01-25 |
Century Therapeutics Inc. | IPSC | Russotti Gregory Chief Technology Officer |
105,000 | $0 | 105,000 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 4:49 pm |
N/A 2032-01-25 |
Century Therapeutics Inc. | IPSC | Flores Osvaldo Chief Executive Officer |
315,000 | $0 | 315,000 (Direct) |
View |
| 2022-01-25 Option Award |
2022-01-27 4:49 pm |
N/A 2032-01-25 |
Century Therapeutics Inc. | IPSC | Carr Douglas VP of Finance and Operations |
35,000 | $0 | 35,000 (Direct) |
View |
| 2021-12-23 Other |
2021-12-28 4:46 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage II L.P. Versant Vantage II GP L.P. Versant Vantage II GP-GP LLC 10% Owner |
371,004 | $0 | 13,630,909 (Direct) |
View |
| 2021-06-22 Conversion |
2021-06-23 5:00 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | FUJIFILM Cellular Dynamics Inc. FUJIFILM Corp FUJIFILM Holdings America Corp FUJIFILM Holdings Corp 10% Owner |
13,974,404 | $0 | 6,955,207 (Direct) |
View |
| 2021-06-22 Conversion |
2021-06-23 4:41 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | BAYER AKTIENGESELLSCHAFT Bayer World Investments B.V. 10% Owner |
41,932,441 | $0 | 12,675,838 (Direct) |
View |
| 2021-06-22 Conversion |
2021-06-23 4:30 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage II L.P. Versant Vantage II GP L.P. Versant Vantage II GP-GP LLC 10% Owner |
37,095,231 | $0 | 13,630,909 (Direct) |
View |
| 2021-06-22 Conversion |
2021-06-22 4:31 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | Casdin Eli Director |
8,636,880 | $0 | 3,206,380 (Indirect) |
View |
| 2021-06-17 Option Award |
2021-06-21 4:34 pm |
N/A 2031-06-17 |
Century Therapeutics Inc. | IPSC | Blackwell Kimberly Director |
19,872 | $0 | 19,872 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 4:33 pm |
N/A 2031-06-17 |
Century Therapeutics Inc. | IPSC | JIMENEZ JOSEPH Director |
19,872 | $0 | 19,872 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 4:32 pm |
N/A 2031-06-17 |
Century Therapeutics Inc. | IPSC | BUTITTA CYNTHIA M Director |
19,872 | $0 | 19,872 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 4:32 pm |
N/A 2031-06-17 |
Century Therapeutics Inc. | IPSC | Carlo Rizzuto Director |
39,744 | $0 | 39,744 (Direct) |
View |
| 2021-06-17 Option Award |
2021-06-21 4:31 pm |
N/A 2031-06-17 |
Century Therapeutics Inc. | IPSC | Riva Alessandro Director |
19,872 | $0 | 19,872 (Direct) |
View |
Ownership |
2021-06-17 5:50 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | BAYER AKTIENGESELLSCHAFT Bayer World Investments B.V. 10% Owner |
0 | $0 | 11,925,838 (Direct) |
View |
Ownership |
2021-06-17 5:28 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | FUJIFILM Cellular Dynamics Inc. FUJIFILM Corp FUJIFILM Holdings America Corp FUJIFILM Holdings Corp 10% Owner |
0 | $0 | 6,955,207 (Direct) |
View |
Ownership |
2021-06-17 5:09 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | Casdin Eli Director |
0 | $0 | 2,456,380 (Indirect) |
View |
Ownership |
2021-06-17 5:07 pm |
N/A 2031-05-21 |
Century Therapeutics Inc. | IPSC | Blackwell Kimberly Director |
0 | $0 | 99,483 (Direct) |
View |
Ownership |
2021-06-17 5:05 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | Versant Venture Capital VI L.P. Versant Ventures VI GP L.P. Versant Ventures VI GP-GP LLC Versant Vantage II L.P. Versant Vantage II GP L.P. Versant Vantage II GP-GP LLC 10% Owner |
0 | $0 | 13,530,909 (Direct) |
View |
Ownership |
2021-06-17 5:05 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | BUTITTA CYNTHIA M Director |
0 | $0 | 98,936 (Direct) |
View |
Ownership |
2021-06-17 5:03 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | Russotti Gregory Chief Technology Officer |
0 | $0 | 472,439 (Direct) |
View |
Ownership |
2021-06-17 5:03 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | Diem Michael Craig Chief Business Officer |
0 | $0 | 498,272 (Direct) |
View |
Ownership |
2021-06-17 5:02 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | Farid Adrienne Chief Operations Officer |
0 | $0 | 504,522 (Direct) |
View |
Ownership |
2021-06-17 5:02 pm |
N/A 2031-05-21 |
Century Therapeutics Inc. | IPSC | Riva Alessandro Director |
0 | $0 | 99,483 (Direct) |
View |
Ownership |
2021-06-17 5:01 pm |
N/A 2029-07-17 |
Century Therapeutics Inc. | IPSC | Borges Luis Chief Scientific Officer |
0 | $0 | 504,522 (Direct) |
View |
Ownership |
2021-06-17 5:01 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | Carr Douglas VP Finance & Operations |
0 | $0 | 219,327 (Direct) |
View |
Ownership |
2021-06-17 5:00 pm |
N/A N/A |
Century Therapeutics Inc. | IPSC | JIMENEZ JOSEPH Director |
0 | $0 | 494,346 (Direct) |
View |